Goldman Sachs
AEHR icon

Goldman Sachs’s Aehr Test Systems AEHR Stock Holding History

Goldman Sachs’s Portfolio AEHR Stock Details AEHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$77.8M Sell
810,036
-452,007
-36% -$41.3M 0.01% 1429
2026
Q1 		$46.8M Buy
1,262,043
+1,086,001
+617% +$34.7M 0.01% 1628
2025
Q4 		$3.55M Buy
176,042
+60,476
+52% +$1.46M ﹤0.01% 4074
2025
Q3 		$3.48M Sell
115,566
-15,401
-12% -$333K ﹤0.01% 3981
2025
Q2 		$1.69M Sell
130,967
-15,030
-10% -$143K ﹤0.01% 4308
2025
Q1 		$1.06M Sell
145,997
-31,079
-18% -$344K ﹤0.01% 4642
2024
Q4 		$2.94M Buy
177,076
+6,632
+4% +$88.4K ﹤0.01% 3965
2024
Q3 		$2.19M Buy
170,444
+12,004
+8% +$174K ﹤0.01% 4085
2024
Q2 		$1.77M Buy
158,440
+9,258
+6% +$108K ﹤0.01% 4017
2024
Q1 		$1.85M Buy
149,182
+68,886
+86% +$1.15M ﹤0.01% 3924
2023
Q4 		$2.13M Sell
80,296
-1,800,841
-96% -$52.5M ﹤0.01% 3875
2023
Q3 		$86M Buy
1,881,137
+470,864
+33% +$21.8M 0.02% 798
2023
Q2 		$58.2M Sell
1,410,273
-540,669
-28% -$17.7M 0.01% 991
2023
Q1 		$60.5M Buy
1,950,942
+671,826
+53% +$21.6M 0.01% 945
2022
Q4 		$25.7M Buy
1,279,116
+1,080,057
+543% +$23.1M 0.01% 1730
2022
Q3 		$2.81M Buy
199,059
+186,404
+1,473% +$2.51M ﹤0.01% 3663
2022
Q2 		$95K Sell
12,655
-16,283
-56% -$135K ﹤0.01% 5879
2022
Q1 		$294K Buy
+28,938
New +$370K ﹤0.01% 5668
2021
Q3 		– Sell
-27,823
Closed -$77K – 6195
2021
Q2 		$77K Sell
27,823
-7,538
-21% -$18K ﹤0.01% 6006
2021
Q1 		$89K Buy
+35,361
New +$91.3K ﹤0.01% 5865

Other funds holding AEHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs's AEHR Position: Q2 2026 in Review

Goldman Sachs reduced its Aehr Test Systems (AEHR) stake by 36% in Q2 2026, selling an estimated $41.3M and leaving 810,036 shares worth $77.8M. The position accounts for 0.01% of the portfolio, ranked #1429.

Goldman Sachs first reported a position in AEHR in Q1 2021 and has held it in 20 quarters since. The position peaked at $86M in Q3 2023. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

  • Goldman Sachs held 810,036 shares of Aehr Test Systems worth $77.8M as of Q2 2026.
  • Goldman Sachs sold 452,007 Aehr Test Systems shares in Q2 2026, an estimated $41.3M.
  • Aehr Test Systems made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1429 holding.
  • Goldman Sachs first reported a position in Aehr Test Systems in Q1 2021 and has held it in 20 quarters since.
  • Goldman Sachs's Aehr Test Systems position peaked at $86M in Q3 2023.
  • 262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.